A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion

Christodoulos Xinaris, M. Morigi, V. Benedetti, B. Imberti, A. S. Fabricio, E. Squarcina, A. Benigni, E. Gagliardini, G. Remuzzi

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate for cell-based therapies. However, the major barrier to the effective implementation of MSC-based therapies is the lack of specific homing of exogenously infused cells and overall the inability to drive them to the diseased or damaged tissue. In order to circumvent these limitations, we developed a preconditioning strategy to optimize MSC migration efficiency and potentiate their beneficial effect at the site of injury. Initially, we screened different molecules by using an in vitro injury-migration setting, and subsequently, we evaluated the effectiveness of the different strategies in mice with acute kidney injury (AKI). Our results showed that preconditioning of MSCs with IGF-1 before infusion improved cell migration capacity and restored normal renal function after AKI. The present study demonstrates that promoting migration of MSCs could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair.

Original languageEnglish
Pages (from-to)423-436
Number of pages14
JournalCell Transplantation
Volume22
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Stem cells
Mesenchymal Stromal Cells
Cell Movement
Repair
Tissue
Wounds and Injuries
Cell- and Tissue-Based Therapy
Acute Kidney Injury
Insulin-Like Growth Factor I
Bone
Bone Marrow
Kidney
Molecules
Therapeutics

Keywords

  • Acute kidney injury (AKI)
  • Insulin-like growth factor-1 (IGF-1)
  • Kidney repair
  • Mesenchymal stem cells (MSCs)
  • Migration

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering

Cite this

A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. / Xinaris, Christodoulos; Morigi, M.; Benedetti, V.; Imberti, B.; Fabricio, A. S.; Squarcina, E.; Benigni, A.; Gagliardini, E.; Remuzzi, G.

In: Cell Transplantation, Vol. 22, No. 3, 2013, p. 423-436.

Research output: Contribution to journalArticle

Xinaris, Christodoulos ; Morigi, M. ; Benedetti, V. ; Imberti, B. ; Fabricio, A. S. ; Squarcina, E. ; Benigni, A. ; Gagliardini, E. ; Remuzzi, G. / A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion. In: Cell Transplantation. 2013 ; Vol. 22, No. 3. pp. 423-436.
@article{686be6972c9a46bf99c11788a34a0f75,
title = "A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion",
abstract = "Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate for cell-based therapies. However, the major barrier to the effective implementation of MSC-based therapies is the lack of specific homing of exogenously infused cells and overall the inability to drive them to the diseased or damaged tissue. In order to circumvent these limitations, we developed a preconditioning strategy to optimize MSC migration efficiency and potentiate their beneficial effect at the site of injury. Initially, we screened different molecules by using an in vitro injury-migration setting, and subsequently, we evaluated the effectiveness of the different strategies in mice with acute kidney injury (AKI). Our results showed that preconditioning of MSCs with IGF-1 before infusion improved cell migration capacity and restored normal renal function after AKI. The present study demonstrates that promoting migration of MSCs could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair.",
keywords = "Acute kidney injury (AKI), Insulin-like growth factor-1 (IGF-1), Kidney repair, Mesenchymal stem cells (MSCs), Migration",
author = "Christodoulos Xinaris and M. Morigi and V. Benedetti and B. Imberti and Fabricio, {A. S.} and E. Squarcina and A. Benigni and E. Gagliardini and G. Remuzzi",
year = "2013",
doi = "10.3727/096368912X653246",
language = "English",
volume = "22",
pages = "423--436",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "3",

}

TY - JOUR

T1 - A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion

AU - Xinaris, Christodoulos

AU - Morigi, M.

AU - Benedetti, V.

AU - Imberti, B.

AU - Fabricio, A. S.

AU - Squarcina, E.

AU - Benigni, A.

AU - Gagliardini, E.

AU - Remuzzi, G.

PY - 2013

Y1 - 2013

N2 - Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate for cell-based therapies. However, the major barrier to the effective implementation of MSC-based therapies is the lack of specific homing of exogenously infused cells and overall the inability to drive them to the diseased or damaged tissue. In order to circumvent these limitations, we developed a preconditioning strategy to optimize MSC migration efficiency and potentiate their beneficial effect at the site of injury. Initially, we screened different molecules by using an in vitro injury-migration setting, and subsequently, we evaluated the effectiveness of the different strategies in mice with acute kidney injury (AKI). Our results showed that preconditioning of MSCs with IGF-1 before infusion improved cell migration capacity and restored normal renal function after AKI. The present study demonstrates that promoting migration of MSCs could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair.

AB - Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate for cell-based therapies. However, the major barrier to the effective implementation of MSC-based therapies is the lack of specific homing of exogenously infused cells and overall the inability to drive them to the diseased or damaged tissue. In order to circumvent these limitations, we developed a preconditioning strategy to optimize MSC migration efficiency and potentiate their beneficial effect at the site of injury. Initially, we screened different molecules by using an in vitro injury-migration setting, and subsequently, we evaluated the effectiveness of the different strategies in mice with acute kidney injury (AKI). Our results showed that preconditioning of MSCs with IGF-1 before infusion improved cell migration capacity and restored normal renal function after AKI. The present study demonstrates that promoting migration of MSCs could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair.

KW - Acute kidney injury (AKI)

KW - Insulin-like growth factor-1 (IGF-1)

KW - Kidney repair

KW - Mesenchymal stem cells (MSCs)

KW - Migration

UR - http://www.scopus.com/inward/record.url?scp=84877311784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877311784&partnerID=8YFLogxK

U2 - 10.3727/096368912X653246

DO - 10.3727/096368912X653246

M3 - Article

C2 - 22889699

AN - SCOPUS:84877311784

VL - 22

SP - 423

EP - 436

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 3

ER -